Annual Total Long Term Liabilities
$38.94 M
+$38.80 M+26847.82%
December 31, 2023
Summary
- As of March 10, 2025, OPRX annual total long term liabilities is $38.94 million, with the most recent change of +$38.80 million (+26847.82%) on December 31, 2023.
- During the last 3 years, OPRX annual total long term liabilities has risen by +$38.61 million (+11863.01%).
- OPRX annual total long term liabilities is now at all-time high.
Performance
OPRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$36.23 M
-$672.00 K-1.82%
September 30, 2024
Summary
- As of March 10, 2025, OPRX quarterly total long term liabilities is $36.23 million, with the most recent change of -$672.00 thousand (-1.82%) on September 30, 2024.
- Over the past year, OPRX quarterly long term liabilities has stayed the same.
- OPRX quarterly long term liabilities is now -6.95% below its all-time high of $38.94 million, reached on December 31, 2023.
Performance
OPRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
OPRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | 0.0% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | +1546.5% | +539.1% |
OPRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -7.0% | -100.0% |
| 5 y | 5-year | at high | >+9999.0% | -7.0% | -100.0% |
| alltime | all time | at high | -100.0% | -7.0% | -100.0% |
OptimizeRx Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.23 M(-1.8%) |
| Jun 2024 | - | $36.90 M(-0.4%) |
| Mar 2024 | - | $37.06 M(-4.8%) |
| Dec 2023 | $38.94 M(>+9900.0%) | $38.94 M(>+9900.0%) |
| Sep 2023 | - | $121.00 K(>+9900.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $123.20 K(-14.7%) |
| Dec 2022 | $144.50 K(-39.0%) | $144.50 K(-13.4%) |
| Sep 2022 | - | $166.80 K(-12.1%) |
| Jun 2022 | - | $189.80 K(-10.9%) |
| Mar 2022 | - | $212.90 K(-10.1%) |
| Dec 2021 | $236.70 K(-27.3%) | $236.70 K(-9.2%) |
| Sep 2021 | - | $260.60 K(-7.9%) |
| Jun 2021 | - | $282.90 K(-7.2%) |
| Mar 2021 | - | $305.00 K(-6.3%) |
| Dec 2020 | $325.50 K(-94.3%) | $325.50 K(-8.7%) |
| Sep 2020 | - | $356.60 K(-8.0%) |
| Jun 2020 | - | $387.70 K(-87.6%) |
| Mar 2020 | - | $3.14 M(-44.6%) |
| Dec 2019 | $5.67 M(+139.7%) | $5.67 M(+182.3%) |
| Sep 2019 | - | $2.01 M(-2.3%) |
| Jun 2019 | - | $2.05 M(+4.9%) |
| Mar 2019 | - | $1.96 M(-17.2%) |
| Dec 2018 | $2.37 M(>+9900.0%) | $2.37 M(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $1.00 M(0.0%) |
| Mar 2011 | - | $1.00 M(0.0%) |
| Dec 2010 | $1.00 M(>+9900.0%) | $1.00 M(>+9900.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00 |
| Dec 2007 | $50.00 K | - |
FAQ
- What is OptimizeRx annual total long term liabilities?
- What is the all time high annual total long term liabilities for OptimizeRx?
- What is OptimizeRx annual total long term liabilities year-on-year change?
- What is OptimizeRx quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for OptimizeRx?
- What is OptimizeRx quarterly long term liabilities year-on-year change?
What is OptimizeRx annual total long term liabilities?
The current annual total long term liabilities of OPRX is $38.94 M
What is the all time high annual total long term liabilities for OptimizeRx?
OptimizeRx all-time high annual total long term liabilities is $38.94 M
What is OptimizeRx annual total long term liabilities year-on-year change?
Over the past year, OPRX annual total long term liabilities has changed by +$38.80 M (+26847.82%)
What is OptimizeRx quarterly total long term liabilities?
The current quarterly long term liabilities of OPRX is $36.23 M
What is the all time high quarterly long term liabilities for OptimizeRx?
OptimizeRx all-time high quarterly total long term liabilities is $38.94 M
What is OptimizeRx quarterly long term liabilities year-on-year change?
Over the past year, OPRX quarterly total long term liabilities has changed by $0.00 (0.00%)